Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin ER for hot flashes in postmenopausal women
NCT00511953Phase 2Completed
- Sponsor
- Assertio
- Start
- Jun 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hot flashes comparing Gabapentin ER with Placebo (2 arms). Primary endpoints: Frequency of moderate to severe hot flashes at 24 hours and Severity of hot flashes at 13 weeks. Started Jun 2007; status: completed.
02
Drugs
gabapentin
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT00511953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511953.